Navigation Links
Glaucoma May Boost Cardiovascular Death Risk in Blacks
Date:3/11/2008

Inappropriate treatment with beta blockers, other meds also increases odds, study finds

TUESDAY, March 11 (HealthDay News) -- Black people diagnosed and treated for glaucoma and those with high pressure in their eyes may be at increased risk for cardiovascular death, a new study suggests.

"Glaucoma is one of the leading causes of visual impairment worldwide," the researchers from Stony Brook University in Stony Brook, N.Y., wrote as background information in the study. "The most common type, primary open-angle glaucoma, is especially prevalent in populations of African origin, in which it is the foremost cause of blindness."

In addition to higher rates of open-angle glaucoma, blacks also tend to have higher rates of high pressure in their eyes (ocular hypertension) and higher rates of death from chronic disease than whites, the study authors noted.

They analyzed data on 4,092 people, aged 40 to 84 (average age 58.6), who took part in the Barbados Eye Studies of a predominately black population with similar ancestry to black Americans.

During the initial study visits that took place between 1987 and 1992, participants' height, weight and blood pressure were recorded, they were interviewed, and various eye measurements -- including photos of the retina and eye pressure assessments -- were taken.

At the start of the study, 300 participants had glaucoma, including 141 who'd been diagnosed and treated. After nine years of follow-up, 764 (19 percent) of the participants had died.

After the researchers adjusted for other factors, they concluded that glaucoma was not associated with risk of death overall. However, they did find that the risk of cardiovascular death was: 28 percent higher in those with ocular hypertension at the start of the study; 38 percent higher in people who'd previously been diagnosed with or treated for open angle glaucoma; and 91 percent higher in those who'd been treated with a beta blocker drug called timolol maleate.

The findings were published in the March issue of the Archives of Ophthalmology.

"One explanation for the excess mortality [death] found in persons with previously diagnosed open-angle glaucoma could be their longer duration of disease compared with those with newly diagnosed disease," the study authors wrote. "Another explanation for an increased mortality risk could be related to the open-angle glaucoma treatment received."

They noted that inappropriate use, or adverse effects, of beta blockers and other medications used to treat glaucoma may damage the cardiovascular system. They also said there's some evidence that risk factors for ocular hypertension and cardiovascular disease are similar.

"These findings underscore the importance of close monitoring and controlling of adequate intraocular pressure levels in this and other high-risk populations," the researchers concluded.

More information

The U.S. National Eye Institute has more about glaucoma.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
2. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
3. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
4. January is National Glaucoma Awareness Month
5. Cost of glaucoma medications may impact treatment
6. Looking at Glaucoma as a Systemic Disease
7. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
8. Glaucoma surgery in the blink of an eye
9. Glaucoma surgery in the blink of an eye
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. New Method Boosts Cardiac Arrest Survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Glaucoma May Boost Cardiovascular Death Risk in Blacks
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Doctor C ... it attended the January ECRM trade show to continue the marketing and distribution of ... C supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. ...
(Date:1/20/2017)... ... 2017 , ... International Protein, a company based out of Australia that focuses ... January ECRM trade show in Hilton Head, SC. , International Protein was founded ... a line of products that would elevate her fitness regime. At this ECRM trade ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is ... as an educator interacting with countless women who had little knowledge of the female ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R ... Pressure (OPEP) device, was featured in a study indicating superior performance against competitive ... “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: a ... world hunger, and shares the simple and achievable answer. “The Land of More and ... the Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 18, 2017 The Academy of Managed ... Administration (FDA) for its release today of draft ... decision makers can proactively share clinical and economic ... as emerging therapies awaiting FDA approval. ... that AMCP developed during two multi-stakeholder meetings last ...
(Date:1/18/2017)... 2017  EnteroMedics Inc. (NASDAQ: ETRM ... technology to treat obesity, metabolic diseases and other ... underwritten public offering of units for gross proceeds ... and commissions and offering expenses payable by EnteroMedics. ... A Units, priced at a public offering price ...
(Date:1/18/2017)... India , January 18, 2017 ... Imaging Technologies Market by Type: Global Opportunity Analysis and Industry ... size was valued at $2,544 million in 2015 and is ... CAGR of 8.4% from 2016 to 2022. North ... accounted for over three-fourths market share in 2015. Ionizing breast ...
Breaking Medicine Technology: